The research team, led by Anna L.V. Johansson of the Karolinska Institutet and Søren Friis and Mats Lambe and colleagues across the Nordic cancer research community, analysed more than 2.2 million cancer cases diagnosed between 2003 and 2022 across 18 major cancer sites. They compared incidence trends in adults aged 20 to 49 with those aged 50 to 84, and extended some analyses back to 1978 to probe for birth-cohort effects, the statistical fingerprints left behind when entire generations carry elevated risk through life. The Nordic registries are legally mandated, near-complete, and histologically verified in 92 to 97 percent of cases, making the region an unusually clean laboratory for spotting genuine epidemiological signals rather than artefacts of sloppy record-keeping.

The headline finding is stark: early-onset cancer incidence increased for 12 of the 18 cancer sites examined over the two-decade study window. The steepest rises, with estimated annual percent changes of at least 2 percent, occurred in thyroid, colon, kidney cancers, and melanoma. Rates also climbed, more modestly, for rectal, prostate, liver, and corpus uteri cancers as well as multiple myeloma, with smaller increases for cervical, pancreatic, and breast cancers. Only lung and ovarian cancer showed significant declines among the young, a pattern the authors partly attribute to falling smoking prevalence and changing use of hormonal contraceptives.

What makes the study particularly striking is the age gradient buried within the early-onset group. When the researchers stratified patients into five-year age bands, they found that the largest increases for colon, pancreatic, breast, and kidney cancers occurred in adults under 35, while melanoma, thyroid, rectal, liver, and corpus uteri cancers rose fastest in the 35 to 49 bracket. In other words, for several major malignancies, the youngest adults, those in their twenties and early thirties, are experiencing the sharpest acceleration, a pattern that cannot be explained away by screening programmes, which typically target people over 50.

The birth-cohort analysis adds a further layer of concern. Successive generations born from roughly the 1960s onward have carried progressively higher rates of colon cancer, and for rectal, pancreatic, breast, kidney, thyroid cancers, and melanoma, the elevation begins with cohorts born from the late 1970s and 1980s. This generational pattern suggests that exposures acting early in life, in childhood, adolescence, or young adulthood, may be programming elevated cancer risk decades before diagnosis. It also implies that today’s young adults may carry their excess risk into older age, when cancer becomes more common overall, potentially compounding the future disease burden.

Not every trend moved in the same direction across the region. In the four largest countries, Denmark, Finland, Norway, and Sweden, trends for melanoma, colon, rectal, breast, kidney, and thyroid cancers were broadly consistent, but patterns in Iceland, the Faroe Islands, and Greenland were more variable, particularly for melanoma. Sweden stood alone with a rising rate of early-onset pancreatic cancer. Intriguingly, for rectal, prostate, corpus uteri, and cervical cancers, incidence rose exclusively among the young while simultaneously falling among older adults, a divergence that hints at genuinely shifting risk landscapes rather than uniform changes in detection.

So what is driving the rise? The authors are careful to note that the mechanisms are likely multifactorial and vary by cancer type, and that a descriptive registry study cannot assign causation. Obesity is a leading suspect: seven of the nine obesity-related cancer sites defined by the World Health Organization, including colon, rectum, liver, pancreas, corpus uteri, kidney, and thyroid, showed increasing early-onset incidence in the Nordic data. Yet the pattern was inconsistent with the known strength of obesity-cancer associations, suggesting excess body weight alone cannot explain the trends. Related exposures, sedentary lifestyles, shifting dietary patterns high in fat, sugar, and red meat and low in fibre, alcohol, ultraviolet radiation, reproductive changes such as fewer births and later first pregnancies, and genetic predisposition, all remain on the table. Notably, smoking and alcohol consumption have declined among young Nordics, which may be masking even larger increases driven by other factors.

Increased diagnostic scrutiny complicates the picture further. The widespread adoption of ultrasound, computed tomography, and magnetic resonance imaging has lowered the threshold for detecting small tumours, and the dramatic global rise in thyroid cancer is widely attributed at least in part to this diagnostic intensity. Similarly, rising early-onset prostate cancer rates likely reflect opportunistic prostate-specific antigen testing in men under 50, despite the absence of formal screening recommendations. For melanoma, more aggressive biopsying of pigmented lesions may contribute, although the authors also point to an encouraging counter-trend: early-onset melanoma incidence declined in the most recent decade, possibly reflecting the success of sun-protection campaigns and restrictions on tanning salons introduced across the Nordic countries in the 2000s.

Some researchers have proposed a more provocative framework: accelerated biological ageing. Recent generations may accumulate lifestyle and environmental exposures that make their biological age outpace their chronological age, and advanced biological age has been linked to elevated overall cancer risk as well as lung and colorectal cancer in large biobank studies. The hypothesis is attractive because biological ageing is potentially modifiable, opening avenues for primary prevention, but the authors stress that individual-level data on risk factor histories will be needed to test it properly in the Nordic context.

The absolute numbers remain modest. Between the first and last five-year periods of the study, early-onset cases across the 18 sites rose by 9,174, from 47,491 to 56,665, compared with an increase of more than 145,000 cases among older adults. Melanoma accounted for the largest absolute jump in the young, with 2,918 additional cases, followed by thyroid, breast, colon, and kidney cancers. But the authors argue the trajectory matters more than the tally. Young patients face decades of survivorship, potential long-term treatment sequelae, and productivity losses, and healthcare systems will need resources tailored specifically to younger cancer patients. The study’s central message is a call to action: intensify research into modifiable early-life risk factors, strengthen primary prevention starting in childhood and adolescence, and raise clinical awareness of malignancies in a population not traditionally perceived as being at risk.

Subject of Research: Population-based trends in early-onset cancer incidence across seven Nordic countries from 2003 to 2022

Article Title: Trends in early-onset cancer incidence rates in the Nordic countries (2003–2022): a population-based study

Article References: Johansson, A. L., Kønig, S. M., Cardoso, R., Møller, H., Ursin, G., Skog, A., Persson, Å., Birgisson, H., Kristjánsdóttir, L., Tanskanen, T., Dahl-Olsen, E. D., Bray, F., Friis, S., & Lambe, M. (2026). Trends in early-onset cancer incidence rates in the Nordic countries (2003–2022): a population-based study. The Lancet Regional Health – Europe, 70, Article 101858. https://doi.org/10.1016/j.lanepe.2026.101858

Image Credits: AI Generated

DOI: 10.1016/j.lanepe.2026.101858

Keywords: early-onset cancer, Nordic countries, cancer incidence, thyroid cancer, colorectal cancer, birth cohort effects, obesity-related cancers, melanoma, NORDCAN, cancer epidemiology, cancer prevention, young adults